Question special
Faculty Member

Although you note that this study was not powered to show the non-inferiority of the 10 mg dose of Rivaroxaban compared to the 20 mg dose, the data suggests there may be something there to investigate. I think most providers would prefer to treat their patients with the lowest possible dose of anticoagulant that would be efficacious. Since publishing your data, has there been any consideration to further evaluating the non-inferiority of the 10 mg dose for treatment of VTE?